Literature DB >> 29491227

Pathophysiological Significance of Velocity-Based Microvascular Resistance at Maximal Hyperemia in Peripheral Artery Disease.

Kuniyasu Ikeoka1, Shiro Hoshida1, Tetsuya Watanabe1, Yukinori Shinoda1, Tomoko Minamisaka1, Hidetada Fukuoka1, Hirooki Inui1, Keisuke Ueno1, Yasushi Sakata2.   

Abstract

AIM: Maximal hyperemic response, leading to examination of microvascular resistance in lower-limb lesions is not well understood. This study aimed to investigate the infrainguinal arterial physiological response through a hyperemic condition and the pathophysiological significance of microvascular resistance in peripheral artery disease.
METHODS: Sixteen limbs with focal stenosis of the superficial femoral artery (SFA) and 16 control limbs were analyzed. We assessed the fractional flow reserve (FFR), vascular flow reserve (VFR), and hyperemic microvascular resistance (h-MR) of the SFA with a pressure/Doppler flow sensor-tipped combination guidewire before and after endovascular therapy (EVT). Skin perfusion pressure (SPP) on both the dorsal and the plantar sides of the foot was measured at baseline before and after the endovascular procedures.
RESULTS: FFR (p<0.05) and VFR (p<0.05), but not h-MR, improved after EVT. There was no association between h-MR and FFR or VFR before EVT. h-MR was negatively correlated with the dorsal SPP before EVT (r=-0.589, p<0.05). h-MR in patients with high h-MR before EVT significantly decreased after EVT (p<0.05). Patients with high, but not those with low, h-MR before EVT exhibited a significant increase in dorsal and plantar SPP after EVT (p<0.05, each).
CONCLUSION: EVT for SFA stenosis improved FFR and VFR comprehensively, with no apparent change in h-MR. However, high h-MR before EVT may play a predictive role for limb perfusion improvement associated with h-MR reduction after EVT.

Entities:  

Keywords:  Combination guidewire; Endovascular therapy; Microvascular resistance; Skin perfusion pressure; Superficial femoral artery

Mesh:

Year:  2018        PMID: 29491227      PMCID: PMC6224199          DOI: 10.5551/jat.43117

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  14 in total

1.  Assessment of lower limb flow and adequate intra-arterial papaverine doses to achieve maximal hyperemia in elder subjects.

Authors:  Kojiro Miki; Kenichi Fujii; Masashi Fukunaga; Machiko Nishimura; Tetsuo Horimatsu; Ten Saita; Hiroto Tamaru; Takahiro Imanaka; Masahiko Shibuya; Mitsumasa Ohyanagi; Tohru Masuyama
Journal:  Cardiovasc Interv Ther       Date:  2014-11-13

2.  Efficacy of Ultrasonography at the Ankle Level for Estimation of Pedal Microcirculation.

Authors:  Naomi Sekiya; Shigeru Ichioka
Journal:  Ann Vasc Dis       Date:  2015-08-20

Review 3.  Endothelial and neuro-humoral control of coronary blood flow in health and disease.

Authors:  E Bassenge; G Heusch
Journal:  Rev Physiol Biochem Pharmacol       Date:  1990       Impact factor: 5.545

4.  Effect of single tibial artery revascularization on microcirculation in the setting of critical limb ischemia.

Authors:  Osami Kawarada; Satoshi Yasuda; Kunihiro Nishimura; Shingo Sakamoto; Miyuki Noguchi; Yasuomi Takahi; Koichiro Harada; Masaharu Ishihara; Hisao Ogawa
Journal:  Circ Cardiovasc Interv       Date:  2014-08-19       Impact factor: 6.546

5.  Increased hyperaemic coronary microvascular resistance adds to the presence of myocardial ischaemia.

Authors:  Froukje Nolte; Tim P van de Hoef; Martijn Meuwissen; Michiel Voskuil; Steven A J Chamuleau; José P S Henriques; Hein J Verberne; Berthe L F van Eck-Smit; Karel T Koch; Robbert J de Winter; Jos A E Spaan; Jan G P Tijssen; Maria Siebes; Jan J Piek
Journal:  EuroIntervention       Date:  2014       Impact factor: 6.534

Review 6.  Pathophysiology of Intermittent Claudication in Peripheral Artery Disease.

Authors:  Naomi M Hamburg; Mark A Creager
Journal:  Circ J       Date:  2017-01-26       Impact factor: 2.993

7.  Postprocedural Skin Perfusion Pressure Correlates With Clinical Outcomes 1 Year After Endovascular Therapy for Patients With Critical Limb Ischemia.

Authors:  Shin Okamoto; Osamu Iida; Masato Nakamura; Yasutaka Yamauchi; Masashi Fukunaga; Yoshiaki Yokoi; Yoshimitsu Soga; Kan Zen; Keisuke Hirano; Nobuhiro Suematsu; Kenji Suzuki; Yoshiaki Shintani; Yusuke Miyashita; Kazushi Urasawa; Ikuro Kitano; Terutoshi Yamaoka; Norihiko Ohura; Toshimitsu Hamasaki; Masaaki Uematsu; Shinsuke Nanto
Journal:  Angiology       Date:  2015-02-04       Impact factor: 3.619

8.  Vascular flow reserve immediately after infrapopliteal intervention as a predictor of wound healing in patients with foot tissue loss.

Authors:  Masashi Fukunaga; Kenichi Fujii; Daizo Kawasaki; Machiko Nishimura; Tetsuo Horimatsu; Ten Saita; Kojiro Miki; Hiroto Tamaru; Takahiro Imanaka; Yoshiro Naito; Tohru Masuyama
Journal:  Circ Cardiovasc Interv       Date:  2015-06       Impact factor: 6.546

9.  Single-wire pressure and flow velocity measurement to quantify coronary stenosis hemodynamics and effects of percutaneous interventions.

Authors:  Maria Siebes; Bart-Jan Verhoeff; Martijn Meuwissen; Robbert J de Winter; Jos A E Spaan; Jan J Piek
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

10.  Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.

Authors:  Michael D Dake; Gary M Ansel; Michael R Jaff; Takao Ohki; Richard R Saxon; H Bob Smouse; Lindsay S Machan; Scott A Snyder; Erin E O'Leary; Anthony O Ragheb; Thomas Zeller
Journal:  Circulation       Date:  2016-03-11       Impact factor: 29.690

View more
  1 in total

1.  Pressure- and Velocity-Based Physiological Assessment of Stenotic Lesions at Hyperemia in Superficial Femoral Artery Disease: Importance of Hyperemic Stenosis Resistance.

Authors:  Kuniyasu Ikeoka; Tetsuya Watanabe; Yukinori Shinoda; Tomoko Minamisaka; Hidetada Fukuoka; Hirooki Inui; Keisuke Ueno; Soki Inoue; Kentaro Mine; Shiro Hoshida
Journal:  Ann Vasc Dis       Date:  2019-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.